424 related articles for article (PubMed ID: 21307267)
1. Inhibition of amyloid-beta (Abeta) peptide-binding alcohol dehydrogenase-Abeta interaction reduces Abeta accumulation and improves mitochondrial function in a mouse model of Alzheimer's disease.
Yao J; Du H; Yan S; Fang F; Wang C; Lue LF; Guo L; Chen D; Stern DM; Gunn Moore FJ; Xi Chen J; Arancio O; Yan SS
J Neurosci; 2011 Feb; 31(6):2313-20. PubMed ID: 21307267
[TBL] [Abstract][Full Text] [Related]
2. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction.
Takuma K; Yao J; Huang J; Xu H; Chen X; Luddy J; Trillat AC; Stern DM; Arancio O; Yan SS
FASEB J; 2005 Apr; 19(6):597-8. PubMed ID: 15665036
[TBL] [Abstract][Full Text] [Related]
3. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.
Lustbader JW; Cirilli M; Lin C; Xu HW; Takuma K; Wang N; Caspersen C; Chen X; Pollak S; Chaney M; Trinchese F; Liu S; Gunn-Moore F; Lue LF; Walker DG; Kuppusamy P; Zewier ZL; Arancio O; Stern D; Yan SS; Wu H
Science; 2004 Apr; 304(5669):448-52. PubMed ID: 15087549
[TBL] [Abstract][Full Text] [Related]
4. Methylene Blue Improves Brain Mitochondrial ABAD Functions and Decreases Aβ in a Neuroinflammatory Alzheimer's Disease Mouse Model.
Zakaria A; Hamdi N; Abdel-Kader RM
Mol Neurobiol; 2016 Mar; 53(2):1220-1228. PubMed ID: 25601181
[TBL] [Abstract][Full Text] [Related]
5. Decreased proteolytic activity of the mitochondrial amyloid-β degrading enzyme, PreP peptidasome, in Alzheimer's disease brain mitochondria.
Alikhani N; Guo L; Yan S; Du H; Pinho CM; Chen JX; Glaser E; Yan SS
J Alzheimers Dis; 2011; 27(1):75-87. PubMed ID: 21750375
[TBL] [Abstract][Full Text] [Related]
6. ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice.
Xiao X; Chen Q; Zhu X; Wang Y
Neurobiol Aging; 2019 Sep; 81():77-87. PubMed ID: 31252207
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mitochondrial enzyme ABAD restores the amyloid-β-mediated deregulation of estradiol.
Lim YA; Grimm A; Giese M; Mensah-Nyagan AG; Villafranca JE; Ittner LM; Eckert A; Götz J
PLoS One; 2011; 6(12):e28887. PubMed ID: 22174920
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy A; Trippier PC
J Med Chem; 2019 May; 62(9):4252-4264. PubMed ID: 30444369
[TBL] [Abstract][Full Text] [Related]
9. Interaction of amyloid binding alcohol dehydrogenase/Abeta mediates up-regulation of peroxiredoxin II in the brains of Alzheimer's disease patients and a transgenic Alzheimer's disease mouse model.
Yao J; Taylor M; Davey F; Ren Y; Aiton J; Coote P; Fang F; Chen JX; Yan SD; Gunn-Moore FJ
Mol Cell Neurosci; 2007 Jun; 35(2):377-82. PubMed ID: 17490890
[TBL] [Abstract][Full Text] [Related]
10. Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.
Valaasani KR; Sun Q; Hu G; Li J; Du F; Guo Y; Carlson EA; Gan X; Yan SS
Curr Alzheimer Res; 2014 Feb; 11(2):128-36. PubMed ID: 24479630
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction and Alzheimer's disease: role of amyloid-beta peptide alcohol dehydrogenase (ABAD).
Yan SD; Stern DM
Int J Exp Pathol; 2005 Jun; 86(3):161-71. PubMed ID: 15910550
[TBL] [Abstract][Full Text] [Related]
12. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?
Dragicevic N; Bradshaw PC; Mamcarz M; Lin X; Wang L; Cao C; Arendash GW
Neuroscience; 2011 Jun; 185():135-49. PubMed ID: 21514369
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.
Rönnbäck A; Pavlov PF; Mansory M; Gonze P; Marlière N; Winblad B; Graff C; Behbahani H
J Neurochem; 2016 Feb; 136(3):497-502. PubMed ID: 26500157
[TBL] [Abstract][Full Text] [Related]
15. Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction.
Morsy A; Maddeboina K; Gao J; Wang H; Valdez J; Dow LF; Wang X; Trippier PC
ACS Chem Neurosci; 2022 Jul; 13(14):2176-2190. PubMed ID: 35802826
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial β-amyloid in Alzheimer's disease.
Borger E; Aitken L; Muirhead KE; Allen ZE; Ainge JA; Conway SJ; Gunn-Moore FJ
Biochem Soc Trans; 2011 Aug; 39(4):868-73. PubMed ID: 21787315
[TBL] [Abstract][Full Text] [Related]
18. ABAD: a potential therapeutic target for Abeta-induced mitochondrial dysfunction in Alzheimer's disease.
Marques AT; Fernandes PA; Ramos MJ
Mini Rev Med Chem; 2009 Jul; 9(8):1002-8. PubMed ID: 19601895
[TBL] [Abstract][Full Text] [Related]
19. [Mitochondrial enzyme ABAD and its role in the development and treatment of Alzheimer's disease].
Benek O; Musílek K; Kuca K
Ceska Slov Farm; 2012 Aug; 61(4):144-9. PubMed ID: 23251955
[TBL] [Abstract][Full Text] [Related]
20. Behavioral stress causes mitochondrial dysfunction via ABAD up-regulation and aggravates plaque pathology in the brain of a mouse model of Alzheimer disease.
Seo JS; Lee KW; Kim TK; Baek IS; Im JY; Han PL
Free Radic Biol Med; 2011 Jun; 50(11):1526-35. PubMed ID: 21382475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
